Glucosamine inhibits epithelial-to-mesenchymal transition and migration of retinal pigment epithelium cells in culture and morphologic changes in a mouse model of proliferative vitreoretinopathy
Open Access
- 1 April 2011
- journal article
- Published by Wiley in Acta Ophthalmologica
- Vol. 89 (6) , e505-e514
Abstract
Purpose: To explore the effect of glucosamine (GlcN) on transforming growth factor (TGF)-β signalling and several processes involved in proliferative vitreoretinopathy (PVR). Methods: We evaluated the surface levels of TGF-β receptor and its binding of TGF-β in ARPE-19 cells. Release of cytokines and collagen, and expression of signalling intermediates were quantified. Migration was qualitatively and quantitatively examined. The morphology of cells undergoing PVR in vitro and in a mouse PVR model was observed. Results: Glucosamine reduced the surface levels of TGF-β receptor and the ability of ARPE-19 cells to bind TGF-β. In ARPE-19 cells, TGF-β1 plus epidermal growth factor (EGF) or TGF-β2 increased the expression of alpha-smooth muscle actin (α-SMA) and decreased the expression of zona occludens protein (ZO-1). Transforming growth factor-(β2) also caused the release of platelet-derived growth factor (PDGF), connective tissue growth factor (CTGF) and type 1 collagen and increased the phosphorylation of SMAD2 and SMAD3. Platelet-derived growth factor and CTGF stimulated cell migration, and TGF-β2 stimulated wound closure, contraction of collagen and changes in cell morphology. Conclusions: Treatment with GlcN counteracted all of these effects, and its administration in the mouse model reduced the morphologic appearance of PVR. Glucosamine could inhibit the TGF-β signalling pathway in retinal pigment epithelium cells and several of the downstream events associated with epithelial–mesenchymal transition and PVR.Keywords
This publication has 27 references indexed in Scilit:
- TGFb in fibroproliferative diseases in the eyeFrontiers in Bioscience-Scholar, 2009
- Inhibitory Effects of Glucosamine on Endotoxin-Induced Uveitis in Lewis RatsInvestigative Ophthalmology & Visual Science, 2008
- Connective Tissue Growth Factor as a Mediator of Intraocular FibrosisInvestigative Ophthalmology & Visual Science, 2008
- The Role of Gremlin, a BMP Antagonist, and Epithelial-to-Mesenchymal Transition in Proliferative VitreoretinopathyInvestigative Ophthalmology & Visual Science, 2007
- Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathyEye, 2002
- Proliferative vitreoretinopathy—developments in adjunctive treatment and retinal pathologyEye, 2002
- Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathyOphthalmology, 2001
- Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitroKidney International, 1999
- Retinal Pigment Epithelial Cells Secrete and Respond to Hepatocyte Growth FactorBiochemical and Biophysical Research Communications, 1998
- Growth Factors in Vitreous and Subretinal Fluid Cells from Patients with Proliferative VitreoretinopathyOphthalmic Research, 1993